Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | ZTS | TAK | NBIX | UTHR |
| Company | Recursion Pharmaceuticals Inc Cl A | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 8.93 | 170.00 | 13.21 | 136.55 | 270.44 |
| High | 9.20 | 172.15 | 13.38 | 137.27 | 275.53 |
| Low | 8.22 | 167.96 | 13.20 | 133.57 | 268.65 |
| Last | 8.28 | 169.56 | 13.35 | 135.41 | 275.13 |
| Change | -0.59 | +0.12 | +0.32 | -1.25 | +4.68 |
| % Change | -6.65% | +0.07% | +2.46% | -0.91% | +1.73% |
| Volume | 6,518,000 | 4,088,400 | 1,854,900 | 1,537,300 | 1,143,100 |
| 20-Day Average Volume | 5,299,230 | 2,517,495 | 1,435,955 | 726,635 | 517,975 |
| Previous Close | 8.87 | 169.44 | 13.03 | 136.66 | 270.45 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.12 | 170.13 | 13.21 | 139.53 | 269.60 |
| 20-Day Raw Stochastic | 2.45% | 57.92% | 80.56% | 25.29% | 79.83% |
| 20-Day Relative Strength | 43.21% | 52.12% | 50.02% | 45.55% | 65.14% |
| Weighted Alpha | -44.44 | -4.08 | -16.80 | +39.93 | +32.10 |
| Today's Opinion | 40% Sell | 56% Sell | 88% Sell | 40% Buy | 100% Buy |
| Previous Opinion | 24% Sell | 56% Sell | 100% Sell | 48% Buy | 100% Buy |
| Last Month's Opinion | 40% Sell | 72% Sell | 100% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.31% since 05/23/24 | -0.78% since 05/23/24 | +2.53% since 05/23/24 | -3.63% since 05/23/24 | -0.50% since 05/23/24 |
| Low | 8.22 on 05/31/24 | 167.96 on 05/31/24 | 12.93 on 05/29/24 | 131.90 on 05/29/24 | 264.33 on 05/29/24 |
| High | 9.62 on 05/28/24 | 174.17 on 05/30/24 | 13.38 on 05/31/24 | 142.18 on 05/24/24 | 277.27 on 05/24/24 |
| 1-Month | |||||
| %Chg | +5.88% since 04/30/24 | +6.48% since 04/30/24 | +2.06% since 04/30/24 | -1.55% since 04/30/24 | +17.41% since 04/30/24 |
| Low | 7.73 on 05/01/24 | 158.04 on 05/01/24 | 12.77 on 05/09/24 | 131.90 on 05/29/24 | 236.65 on 05/01/24 |
| High | 10.66 on 05/15/24 | 175.78 on 05/21/24 | 13.49 on 05/14/24 | 145.78 on 05/22/24 | 279.98 on 05/21/24 |
| 3-Month | |||||
| %Chg | -38.48% since 02/29/24 | -14.51% since 02/29/24 | -8.50% since 02/29/24 | +3.84% since 02/29/24 | +21.93% since 02/29/24 |
| Low | 7.14 on 04/19/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 129.15 on 03/01/24 | 221.53 on 04/01/24 |
| High | 13.63 on 03/01/24 | 196.23 on 03/01/24 | 14.87 on 03/07/24 | 148.37 on 03/21/24 | 279.98 on 05/21/24 |
| 6-Month | |||||
| %Chg | +17.45% since 11/29/23 | -3.54% since 11/29/23 | -4.78% since 11/29/23 | +19.26% since 11/29/23 | +18.55% since 11/29/23 |
| Low | 6.50 on 12/01/23 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 114.01 on 11/30/23 | 208.62 on 02/08/24 |
| High | 15.74 on 02/27/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 279.98 on 05/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,108,080 | 77,314,632 | 41,237,824 | 13,753,052 | 11,996,079 |
| Shares Outstanding, K | 237,664 | 456,295 | 3,164,837 | 100,637 | 44,356 |
| Annual Sales | 44,580,000 | 8,544,000,000 | 29,419,960,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -328,070,000 | 2,344,000,000 | 994,060,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 13,790,000 | 2,190,000,000 | 5,397,000,000 | 515,300,000 | 677,700,000 |
| Last Quarter Net Income | -91,370,000 | 599,000,000 | -91,000,000 | 43,400,000 | 306,600,000 |
| 60-Month Beta | 0.85 | 0.86 | 0.56 | 0.28 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 05/09/24 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 0.42 on 05/01/24 | 6.17 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 31.69 | 8.29 | 37.09 | 12.66 |